Despite a sluggish construction industry, corporate sentiment in the economy has rebounded slightly for the first time in three months, attributed to the recovery in semiconductor exports.According to the survey results of the Business Survey Index (BSI) and Economic Sentiment Index (ESI) for March
The growth of leading domestic companies in the medical AI field is becoming evident, as the number of clinical trial applications, approvals, and authorizations rapidly increases. Medical AI involves AI trained on various disease data, analyzing patients’ Computed Tomography (CT) scans or Magnetic
Pharmaceutical companies are expanding their presence into Southeast Asia, particularly Indonesia and Vietnam. There is a high preference for Korean products and a high growth potential in these markets, leading to strong optimism about the possibility of expansion. Among these countries, Indonesia
On Feb. 8, the Fair Trade Commission (FTC) unveiled its agenda for the year, intending to elevate the criteria for designating business conglomerates subject to disclosure. Criticism has been directed at the regulations governing the disclosure of business groups as they are unique to South Korea. T
Kang Stem Biotech announced on Jan. 24 that it received final approval from the Japanese Ministry of Health, Labour and Welfare on Jan. 23 for its application for recognition of the manufacture of specific cell processed products.Through this approval, the company will receive adipose tissue from pa
JW Pharmaceutical announced on Jan. 15 that it has received approval from the Malaysian National Pharmaceutical Regulatory Agency (NPRA) for a phase 3 clinical trial plan, or investigational new drug (IND), of its gout treatment drug Epaminurad (code name URC102).The Phase 3 clinical trial for Epami
The 42nd JP Morgan Healthcare Conference is set to take place from Jan. 8 to 11 in San Francisco, California, in the U.S. This annual event, held every January, is renowned as the world’s largest healthcare investment venue where major global pharmaceutical companies, emerging biotech firms, and pro
Korea and the Gulf Cooperation Council (GCC) have finalized negotiations on a free trade agreement (FTA). The Korea-GCC FTA is Korea’s twenty-fifth FTA and the second with the Arab world after the Korea-United Arab Emirates (UAE) Comprehensive Economic Partnership Agreement (CEPA). As Korea has gain
The world’s leading automakers are adopting technologies developed by Korean startups. In particular, major German automakers Benz and BMW are active in using them.PiQuant is a Korean company that develops spectroscopy-based component detection and measurement devices and solutions, and has develope
GC Biopharma Corp’s eight-year endeavor has finally come to fruition as its blood product successfully enters the U.S. market. This achievement marks the first Korean blood product and the seventh new drug to receive approval from the U.S. Food and Drug Administration (FDA).On Dec. 18, GC Biopharma
Waycen (CEO Kim Kyung-nam), a company specializing in AI MEDTECH, proved to be the next-generation global innovation company by winning three CES innovation awards ahead of the world's largest IT exhibition "CES 2024" in Las Vegas in January next year.According to the results of the CES 2024 Innovat
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced that it has launched its blood-based colorectal cancer screening test, ShieldTM, in collaboration with Samsung Medical Center in South Korea.Colorectal cancer (CRC) is one of the most commonly diagnosed cancers and t
On Oct. 26, KGC Korea Ginseng Corporation announced its participation in North America’s largest health food ingredient exhibition, SupplySide WEST 2023.For the first time this year, KGC Korea Ginseng Corporation operated a JUNG KWAN JANG booth at the ingredient exhibition, showcasing a variety of r
ST PHARM, a subsidiary of the Dong-A Socio Group, announced on Oct. 25 that its Oligo manufacturing facility, Banwol Campus, has successfully passed its regular Current Good Manufacturing Practices (cGMP) inspection conducted by the U.S. Food and Drug Administration (FDA). The company has also recei
A U.S. court has approved a request to halt sales of the automatic insulin injection device EOPatch developed by EOFLOW. According to industry sources on Oct. 11, the District Court of Massachusetts accepted an injunction application on Oct. 6 related to a lawsuit over overseas intellectual property
Apple Pay, which made its entrance in South Korea in partnership with Hyundai Card, is set to face scrutiny at the National Audit. The National Assembly is expected to delve into issues such as the reportedly higher fees compared to Samsung Pay during this audit.According to financial sources on Oct
GC Biopharma Corp. announced on Oct. 5 that their therapeutic candidate for Thrombotic Thrombocytopenic Purpura (TTP), “GC1126A,” has received a Rare Drug Designation from the U.S. Food and Drug Administration (FDA).As a result of this designation, GC1126A will benefit from tax deductions on researc
A new technology for robot wheelchairs, which helps persons with lower-limb disabilities go up and down the stairs and move while staying standing, has been developed for the first time in the world.The Korea Institute of Machinery and Materials (President Sang-jin Park, hereinafter referred to as K
The author is an analyst for NH Investment & Securities. He can be reached at seungyeon.han@nhqv.com -- Ed.On Sep 26, the share price of HanAll Biopharma partner Immunovant jumped by over 97% on surprise interim data from the IMVT-1402 phase I trial. Encouraging results were reported in terms of bot
On Sept. 13, Doosan Bobcat reported that over a thousand of its employees from business locations in 12 countries worldwide took part in community service activities on Sept. 12. The activities were on a relay that started from Korea and passed through Asia, the Middle East, Europe, Africa, and the